These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease. Gomez G Front Immunol; 2019; 10():175. PubMed ID: 30792720 [TBL] [Abstract][Full Text] [Related]
4. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573 [TBL] [Abstract][Full Text] [Related]
6. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy. Kanagaratham C; El Ansari YS; Lewis OL; Oettgen HC Front Immunol; 2020; 11():603050. PubMed ID: 33362785 [TBL] [Abstract][Full Text] [Related]
7. Use of omalizumab in the treatment of food allergy and anaphylaxis. Lieberman JA; Chehade M Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311 [TBL] [Abstract][Full Text] [Related]
8. Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα mAbs. Khodoun MV; Morris SC; Shao WH; Potter C; Angerman E; Kiselev A; Yarawsky AE; Herr AB; Klausz K; Otte A; Peipp M; Finkelman FD J Allergy Clin Immunol; 2021 May; 147(5):1838-1854.e4. PubMed ID: 33326804 [TBL] [Abstract][Full Text] [Related]
18. Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy. Suber J; Zhang Y; Ye P; Guo R; Burks AW; Kulis MD; Smith SA; Iweala OI Front Immunol; 2022; 13():974374. PubMed ID: 36248809 [TBL] [Abstract][Full Text] [Related]
19. Propolis suppresses cytokine production in activated basophils and basophil-mediated skin and intestinal allergic inflammation in mice. Kashiwakura JI; Yoshihara M; Saitoh K; Kagohashi K; Sasaki Y; Kobayashi F; Inagaki I; Kitai Y; Muromoto R; Matsuda T Allergol Int; 2021 Jul; 70(3):360-367. PubMed ID: 33279402 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Kaplan AP; Giménez-Arnau AM; Saini SS Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]